136 related articles for article (PubMed ID: 20010567)
1. Comparative effectiveness $100 million handout.
Dorey E
Nat Biotechnol; 2009 Dec; 27(12):1068. PubMed ID: 20010567
[No Abstract] [Full Text] [Related]
2. Quantum grants: request for applications from the NIBIB.
Harrington DP
J Am Coll Radiol; 2006 Jun; 3(6):398-9. PubMed ID: 17412092
[No Abstract] [Full Text] [Related]
3. War or cancer.
Hillman BJ
J Am Coll Radiol; 2007 Jun; 4(6):345-6. PubMed ID: 17544133
[No Abstract] [Full Text] [Related]
4. [The recent decision of the German Federal Social Court regarding funding of studies: will oncological studies in Germany be terminated for financial reasons?].
Jacobs VR
Onkologie; 2004 Dec; 27(6):589-90. PubMed ID: 15603059
[No Abstract] [Full Text] [Related]
5. [Establishing ophthalmology in the research framework programs of the European Union].
Scholl HP; Wheeler-Schilling TH; Zrenner E; Holz FG
Ophthalmologe; 2006 Feb; 103(2):91-9. PubMed ID: 16437232
[TBL] [Abstract][Full Text] [Related]
6. Recent highlights of EU-funded medical research projects. Provided by CORDIS, the official information service for participation in the EU research programmes.
N Biotechnol; 2008; 25(2-3):108-10. PubMed ID: 18824149
[No Abstract] [Full Text] [Related]
7. Healthcare ROI. Medical research, comparative-effectiveness studies deserve investment.
May D
Mod Healthc; 2013 Feb; 43(8):23. PubMed ID: 23516786
[No Abstract] [Full Text] [Related]
8. Health information technology: improving quality and value of patient care.
Tooker J
MedGenMed; 2005 Jun; 7(2):44. PubMed ID: 16369422
[No Abstract] [Full Text] [Related]
9. NIH 'hubs' aid translation.
Fox JL
Nat Biotechnol; 2014 Jul; 32(7):608. PubMed ID: 25004219
[No Abstract] [Full Text] [Related]
10. Support for a publicly funded health system in the USA.
The Lancet
Lancet; 2017 Nov; 390(10108):2122. PubMed ID: 29143742
[No Abstract] [Full Text] [Related]
11. [Rare diseases. Funding programs in Germany and Europe].
Wetterauer B; Schuster R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 May; 51(5):519-28. PubMed ID: 18425694
[TBL] [Abstract][Full Text] [Related]
12. Biotechs get $1 billion windfall in R&D tax credits.
Thiel K
Nat Biotechnol; 2009 Dec; 27(12):1066. PubMed ID: 20010563
[No Abstract] [Full Text] [Related]
13. ARRA boosts cancer programs but impact on personalized medicine unclear.
Ratner M
Nat Biotechnol; 2009 Dec; 27(12):1062. PubMed ID: 20010559
[No Abstract] [Full Text] [Related]
14. [Health economic evaluation of rehabilitation programmes in the "rehabilitation sciences" research funding programme in Germany].
Krauth C; Hessel F; Klingelhöfer HE; Schweikert B; Hansmeier T; Wasem J
Rehabilitation (Stuttg); 2005 Oct; 44(5):297-306. PubMed ID: 16208593
[TBL] [Abstract][Full Text] [Related]
15. Federal stimulus adds momentum to sequencing stampede.
Fox JL
Nat Biotechnol; 2009 Dec; 27(12):1061-2. PubMed ID: 20010558
[No Abstract] [Full Text] [Related]
16. Increasing number of companies found ineligible for SBIR funding.
Bouchie A
Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384
[No Abstract] [Full Text] [Related]
17. Chasing biotech, state by state--winners and losers.
Wilan KH
Nat Biotechnol; 2005 Feb; 23(2):175-9. PubMed ID: 15696143
[No Abstract] [Full Text] [Related]
18. Federal budget. Dems join Bush to boost HIV/AIDS program funds.
AIDS Policy Law; 2001 Jun; 16(12):1, 4. PubMed ID: 11682827
[No Abstract] [Full Text] [Related]
19. Cell Biology. NIH effort gambles on mysterious extracellular RNAs.
Leslie M
Science; 2013 Aug; 341(6149):947. PubMed ID: 23990535
[No Abstract] [Full Text] [Related]
20. Follow the money!
Wallner PE
J Am Coll Radiol; 2005 Jan; 2(1):81. PubMed ID: 17411767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
